---
schema_version: "secwatch.filing_event.v1"
accession: "0001808220-24-000099"
form_type: "8-K"
ticker: "GOCO"
cik: "0001808220"
company_name: "GoHealth, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:09:31.649654+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoHealth Q2 2024 net revenues $105.9M, down 26% YoY; net loss improves to $59.3M

## Summary
- Net revenues of $105.9M, a decrease of $36.9M from $142.8M in Q2 2023.
- Submissions of 152,394, down 6% YoY; internal captive agents grew, offset by GoPartner Solutions decline.
- Net loss of $59.3M, an improvement of $10.9M from prior year loss of $70.2M.
- Adjusted EBITDA of negative $12.3M vs positive $0.8M YoY, a decrease of $13.1M.
- TTM cash flow from operations of $53.8M, down from $85.9M in prior period.

## SEC filing metadata
- accession: 0001808220-24-000099
- form_type: 8-K
- ticker: GOCO
- cik: 0001808220
- company_name: GoHealth, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808220/000180822024000099/0001808220-24-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808220/000180822024000099/goco-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808220-24-000099
- JSON: https://secwatch.observer/filing/0001808220-24-000099.json
- Plain text: https://secwatch.observer/filing/0001808220-24-000099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
